Rchr
J-GLOBAL ID:202001009703604297   Update date: Nov. 21, 2024

Yatomi Taisuke

ヤトミ タイスケ | Yatomi Taisuke
Affiliation and department:
Other affiliations (1):
  • Yokohama City University Graduate School of Medicine  Department of Physiology   Senior Researcher
Research field  (1): Psychiatry
Research keywords  (1): Psychopharmacology, big data analysis, brain imaging study, pharmacoepidemiology
Research theme for competitive and other funds  (3):
  • 2023 - 2025 Verification of the efficacy of ketamine for treatment-resistant depression and elucidation of the mechanism of its therapeutic effect
  • 2021 - 2024 Analysis of inappropriate use of psychotropics, and cohort study of suicide attempts including overdose and transition of the elderly psychiatric diagnoses
  • 2022 - 2023 新型コロナウイルス感染症患者の重症化因子同定及びその後の精神疾患発症に関する研究
Papers (8):
  • Taisuke Yatomi, Dardo Tomasi, Hideaki Tani, Shinichiro Nakajima, Sakiko Tsugawa, Nobuhiro Nagai, Teruki Koizumi, Waki Nakajima, Mai Hatano, Hiroyuki Uchida, et al. α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality. Frontiers in Neural Circuits. 2024. 18
  • Mai Hatano, Waki Nakajima, Hideaki Tani, Hiroyuki Uchida, Tomoyuki Miyazaki, Tetsu Arisawa, Yuuki Takada, Sakiko Tsugawa, Akane Sano, Kotaro Nakano, et al. Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography. Molecular Psychiatry. 2024
  • *Yohei Ohtani, *Hideaki Tani, Kie Nomoto-Takahashi, Taisuke Yatomi, Kengo Yonezawa, Sota Tomiyama, Nobuhiro Nagai, Keisuke Kusudo, Shiori Honda, Shinichiro Nakajima, et al. Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial. Psychiatry and Clinical Neurosciences. 2024
  • Yuna Takahashi*, Taisuke Yatomi*, Naohito Yamaguchi, Kimio Yoshimura, Satoko Hori, Hiroyuki Uchida (*These authors contributed equally to this work.). Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection. Pharmacopsychiatry. 2024. 57. 04. 186-190
  • Yonezawa K, Uchida H, Yatomi T, Ohtani Y, Nomoto-Takahashi K, Nakajima S, Mimura M, Tani H. Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression. Pharmacopsychiatry. 2023. 57. 01. 35-40
more...
MISC (1):
  • 彌富 泰佑, 内田 貴仁, 竹内 啓善, 倉持 信, 三村 將, 内田 裕之. ステロイド性抗炎症薬内服者の向精神薬処方パターン 本邦のレセプトデータ解析(Prescription patterns of psychotropic drugs in patients who were receiving steroidal anti-inflammatory drugs: analysis of Japanese national prescription data). 日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集. 2019. 29回・49回. 148-148
Lectures and oral presentations  (17):
  • Positive Correlation between AMPA Receptor Density and Local and Global Functional Centrality: [11C]K-2 PET and Resting-State fMRI Study
    (2024 American Society of Clinical Psychopharmacology Annual Meeting 2024)
  • Positive Correlation between AMPA Receptor Density and Local and Global Functional Centrality: [11C]K-2 PET and Resting-State fMRI Study
    (35th CINP World Congress 2024)
  • Ketamine alters AMPA receptor distribution of patients with treatment-resistant depression: PET study using [11C]K-2
    (The 2024 Society of Biological Psychiatry 2024)
  • Positive Correlation between AMPA Receptor Density and Local and Global Functional centrality: [11C]K-2 PET and Resting-State fMRI Study
    (The 2024 Society of Biological Psychiatry 2024)
  • AMPA Receptor Imaging in Mood Disorders Using PET-MRI (As a talk)
    (Baylor College of Medicine, Houston, 2024.5.6. 2024)
more...
Education (2):
  • 2021 - 現在 Ph.D. course: Psychiatry, Keio University School of Medicine
  • - 2015 Keio University
Professional career (1):
  • M.D. (School of Medicine, Keio University)
Work history (6):
  • 2023/04 - 現在 日本学術振興会特別研究員(DC2)
  • 2017/04 - 現在 Keio University School of Medicine Department of Neuropsychiatry
  • 2019/04 - 2021/03 川崎市立川崎病院 精神・神経科
  • 2018/04 - 2019/03 慶應義塾大学病院 精神・神経科
  • 2017/04 - 2018/03 医療法人財団青渓会 駒木野病院
Show all
Awards (8):
  • 2024/05 - Collegium Internationale Neuro-Psychopharmacologicum Student Encouragement Award
  • 2024/05 - The American Society of Clinical Psychopharmacology ASCP New Investigator Award
  • 2023/05 - JSNP JSNP Excellent Presentation Award for CINP2023
  • 2023/05 - Collegium Internationale Neuro-Psychopharmacologicum Student Encouragement Award
  • 2023/03 - 慶應義塾大学 慶應医学大塚普門・房子フェローシップ
Show all
Association Membership(s) (7):
日本生物学的精神医学会 ,  日本神経精神薬理学会 ,  The International College of Neuropsychopharmacology ,  American Psychiatric Association ,  Asian College of Neuropsychopharmacology ,  日本臨床精神神経薬理学会 ,  日本精神神経学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page